Brief: Avidity Biosciences Announces Positive Topline Del-Zota Data In DMD44 Trial
17/03/2025 11:12
March 17 (Reuters) - Avidity Biosciences Inc RNA.O: AVIDITY BIOSCIENCES INC - ANNOUNCES POSITIVE TOPLINE DEL-ZOTA DATA IN DMD44 TRIAL AVIDITY BIOSCIENCES INC - ON TRACK FOR YEAR-END 2025 BLA SUBMISSION FOR DEL-ZOTA IN DMD44 Source text: ID:nPn4RW9SLa Further company coverage: RNA.O ((Reuters.Briefs@thomsonreuters.com))
Recent news on Avidity Biosciences
See all newsFactbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
Brief: Avidity Biosciences Says Record Date Set For February 12, 2026 For Spin-Off